Bildkälla: Stockfoto

Prostatype Q2: Early sales support and interest ahead of the US launch - Redeye

Prostatype Genomics has secured a SEK 22.5m rights issue (pre-cost of some SEK 3.1m), and the Q2 sales have increased to SEK 8K.

Prostatype Genomics has secured a SEK 22.5m rights issue (pre-cost of some SEK 3.1m), and the Q2 sales have increased to SEK 8K.
Börsvärldens nyhetsbrev
ANNONSER